Huluwa Pharmaceutical Group was established in 2008, and its headquarters is located in Hainan Island, which is known as Changshou Island and Health Island. China is a famous pediatric pharmaceutical enterprise and a national high-tech enterprise. It is one of the pharmaceutical companies with the fastest development speed, the strongest R&D strength and the most development potential in the pediatric pharmaceutical industry, and the only pharmaceutical company in China that has been selected as the vice chairman of the Pediatric Branch of the Chinese Medicine Association.
Huluwa Pharmaceutical Group has four standardized production bases that have passed the new GMP certification, namely: Haikou Medicine Valley Production Base, Haikou Bonded Production Base, Guangxi Nanning Production Base and Hebei Chengde Production Base; There are 3/kloc-0 professional production lines for chemicals and traditional Chinese medicine. The production site is managed in full accordance with 5S management mode, and the quality management system strictly implements GMP standards. In recent years, the company has invested hundreds of millions of yuan to build a production base of medicine valley. Six modern pharmaceutical buildings and two intensive office buildings have been built. Production equipment and R&D instruments are at the leading level in China. The company launched an efficient OA office system and a convenient financial management system, which laid a solid foundation for the company's rapid development. 20 15 Huluwa Pharmaceutical Group successfully acquired Nanning Weiwei Pharmaceutical Co., Ltd., including all 65 product approvals, sales network, production equipment, existing employees, and its subordinate Guangxi Pingle traditional Chinese medicine pretreatment and extraction production base, and completed the seamless connection between production and sales on 1 15.
At present, Huluwa Pharmaceutical Group has a series of products with three brands as the main body, namely, Huluwa, Huluwa Dad and Huluwa Mom, with nearly 300 product specifications. The products have covered pediatrics, gynecology, ophthalmology, orthopedics, respiratory, digestive, hepatobiliary, urology, neurology, infectious diseases and other treatment fields. There are 25 products in "Huluwa" pediatric series, covering the treatment fields of cough, cold, fever, diarrhea, spleen strengthening, food accumulation, zinc supplementation, calcium supplementation, antivirus, antibiotics, heat-clearing and detoxification, anemia in children, enuresis in children, etc. "Huluma" gynecological series has 6 products, covering the therapeutic fields of menstruation regulation, beauty, anti-inflammation, nourishing qi and blood, promoting blood circulation and removing blood stasis, stopping bleeding and relieving pain; There are more than 100 adult series products, which have completely covered all the treatment fields of adult common diseases.
Huluwa Pharmaceutical Group has two major sales companies-Hainan Huluwa Pharmaceutical Co., Ltd. and Zhejiang Huluwa Pharmaceutical Co., Ltd., which has subdivided 10 sales regions throughout the country and established 26 regional business divisions. The sales network has covered all provinces in China, including more than 300 counties and cities in more than 300 regions. There are more than 800 medical institutions above the second level and more than 3,000 township hospitals. There are more than 30,000 clinics and hospitals, and more than 50,000 chain pharmacies and single pharmacies. After the successful acquisition of Guangxi Weiwei Pharmaceutical Co., Ltd. on 20/0/5, the company's marketing network became more perfect, and large-scale chain sales channels were merged into the company's marketing network, which effectively supplemented the company's existing marketing channels and enabled the company to complete the full coverage of Chinese mainland's marketing network! Production and sales have increased by more than 30% annually for 7 consecutive years, making it a dark horse in China pharmaceutical industry!
The marketing service of Huluwa Pharmaceutical Group has been upgraded in an all-round way, which not only upgrades and refines the service of dealers, but also makes a new service plan for its own professionalism and occupation, and comprehensively enhances brand creativity, product creativity, promotion creativity and management creativity. Every day, more than 2,000 professional service personnel of Huluwa provide health consultation and after-sales service for patients in towns and sales terminals in more than 2,000 counties and cities in more than 300 regions across the country. From pre-pregnancy, pregnancy, childbirth, infancy, early childhood to school age and then to adulthood, academic educators provide you with customized professional consultation and related services, bringing good news to hundreds of millions of children in China.
Huluwa Pharmaceutical Group attaches great importance to pharmaceutical R&D and scientific and technological innovation, and has a professional R&D institution-Hainan Huluwa Technology Development Co., Ltd., with professional R&D talents. At the same time, more than one new special drug 10 has been successfully developed, with 69 varieties under research and 37 patented drugs with independent intellectual property rights, including 4 design patents. In order to promote the development of ethnic medicine industry in China, the company has established a modern R&D Chinese medicine center, which has effectively promoted the standardization and internationalization of Chinese medicine.